Trials / Conditions / Hepatitis, Viral, Human

Hepatitis, Viral, Human

26 registered clinical trials studyying Hepatitis, Viral, Human — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis NCT05492565	Hospitales Universitarios Virgen del Rocío	—
Unknown	Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination NCT03776760	Kirby Institute	—
Completed	Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines NCT03410953	Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León	Phase 4
Terminated	Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixe NCT02613403	Merck Sharp & Dohme LLC	Phase 2
Completed	Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Pa NCT01804829	Biotest Pharmaceuticals Corporation	Phase 3
Completed	Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002 NCT01532973	Merck Sharp & Dohme LLC	Phase 1
Completed	Computer-Assisted Tailored Cue-card Health [CATCH] Study NCT01170741	RTI International	Phase 1
Completed	A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area NCT00913757	National Cancer Institute (NCI)	—
Completed	Epidemiological Study in Children and Adolescents With Chronic Hepatitis B NCT01163240	Novartis Pharmaceuticals	—
Completed	Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. NCT00915057	Norgine	Phase 2
Completed	HIV and Hepatitis Care Coordination in Methadone Treatment NCT00608192	University of California, San Francisco	N/A
Terminated	Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis NCT00318682	Assistance Publique - Hôpitaux de Paris	—
Completed	Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin NCT00230854	OPKO Health, Inc.	Phase 1
Completed	Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis NCT00116454	ANRS, Emerging Infectious Diseases	Phase 3
Completed	Retrovirus Epidemiology Donor Study-II (REDS-II) NCT00097006	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) NCT00564811	UPECLIN HC FM Botucatu Unesp	N/A
Completed	Genes Involved in Resistance or Susceptibility to Hepatitis B Virus NCT00342186	National Cancer Institute (NCI)	—
Completed	Transfusion Infections Pediatric Prospective Study (TRIPPS) NCT00029406	Naomi Luban	—
Completed	Hepatitis C in Clinically Discordant Hemophilic Siblings NCT00007371	University of North Carolina, Chapel Hill	—
Completed	Risk of Post Transfusion Hepatitis C Virus Infection NCT00005339	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Prospective Study of HIV Infection in Hemophiliacs NCT00005309	Bloodworks	—
Completed	Natural History of Post-transfusion Non-A, Non-B Hepatitis NCT00005306	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Hepatitis Delta Infections in Hemophiliacs NCT00005305	University of North Carolina, Chapel Hill	—
Completed	Delta Hepatitis and Liver Disease in Hemophiliacs NCT00005304	Baylor College of Medicine	—
Completed	Hepatitis B Vaccine Clinical Trial NCT00000583	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3
Completed	Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin NCT00000580	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3